Daroonameh

← Back to results

Brimonidine Tartrate

OTC Ophthalmic RxCUI 1999016
Contents

Overview

Active ingredient
Brimonidine Tartrate
Route
Ophthalmic
Label date
2026-03-31

Indications and usage

Use relieves redness of the eye due to minor eye irritations

Purpose

Redness reliever

Dosage and administration

Directions adults and children 5 years of age and over: instill 1 drop in the affected eye(s) every 6-8 hours do not use more than 4 times daily remove contact lenses before use wait at least 10 minutes before re-inserting contact lenses after use if using other ophthalmic products while using this product, wait at least 5 minutes between each product to avoid contamination, do not touch tip of container to any surface replace cap after each use children under 5 years of age: consult a doctor

Warnings

For external use only Do not use if solution changes color or becomes cloudy Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Do not use

if solution changes color or becomes cloudy

Ask a doctor or pharmacist before use if

Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days

Pregnancy or breast-feeding

If pregnant or breast-feeding, ask a health professional before use.

Active ingredient (label)

Brimonidine tartrate (0.025%)

Inactive ingredients

s benzalkonium chloride, boric acid, calcium chloride dihydrate, glycerin, potassium chloride, sodium borate decahydrate, sodium chloride, water for injection. Hydrochloric acid and/or sodium hydroxide may be used to adjust pH.

Keep out of reach of children

of children. If swallowed, get medical help or contact a Poison Control Center right away.